Compliance with Brazilian Law 12.732: assessing breast cancer treatment delays across different therapeutic modalities (2017-2022)

Read full text
Authors: Marcelo Antonini, Sofia Naira Barbosa Freitas, André P. L. Mattar, Denise Joffily Pereira da Costa Pinheiro, Rodrigo Caires Campos, Letícia Félix, Odair Ferraro, Francisco Pimentel Cavalcante, Felipe Zerwes, Fabrício Palermo Brenelli, Antônio Luiz Frasson, Eduardo Camargo Millen
+1 more Ruffo Freitas‐Júnior
Cited by: 0
References: 18

Abstract

Introduction: Breast cancer (BC) is the most common cancer among women in Brazil and worldwide, followed by non-melanoma skin cancer. Law No. 12,732, of November 22, 2012, stipulates that cancer treatment should begin within 60 days of the anatomopathological diagnosis. However, the time to start treatment is still variable in Brazil. Methods: A cross-sectional observational ecological study was conducted using data on breast cancer in Brazil between 2017 and 2022, obtained from the DATASUS-SISCAN database. Patients with a diagnosis of breast cancer (ICD C50), the federative unit (UF) of residence, and the treatment modality were considered. Five-time intervals were defined for the start of treatment. The χ² and Z tests of two proportions were used, considering a 95% confidence interval (p

Fields of Study & Subjects

Breast Cancer Treatment Studies Women's cancer prevention and management Global Cancer Incidence and Screening

Publication details

Journal / source
Mastology
Volume
35
Publication date
13 February 2026
Language
EN